Phase 2 Study of TVB-2640 in KRAS Non-Small Cell Lung Carcinomas
Phase 2 Study of TVB-2640 in KRAS Non-Small Cell Lung Carcinomas
Active, not recruiting · NCT03808558 · Registry updated 2026-05-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 2 Study of TVB-2640 in KRAS Non-Small Cell Lung Carcinomas | KRAS Gene Mutation | Active, not recruiting | Phase 2 | 2026-05-22 | NCT03808558 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cancer Prevention Research Institute of Texas | 29 |
| David E Gerber | 1 |
| Gateway for Cancer Research | 32 |
| Sagimet Biosciences Inc. | 4 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Cincinnati | Cincinnati | United States | 79 |
| University of Texas Southwestern Medical Center | Dallas | United States | 1 |